Pays: Irlande
Langue: anglais
Source: HPRA (Health Products Regulatory Authority)
LEVAMISOLE HYDROCHLORIDE, RAFOXANIDE
Pharvet (Ireland) Ltd
QP52AE51
LEVAMISOLE HYDROCHLORIDE, RAFOXANIDE
Unknown
Oral Suspension
LM-Licensed Merchant
Bovine, Ovine
Levamisole, combinations
Endoparasiticide
Authorised
2012-02-03
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Triazole Fluke and Worm Drench 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral suspension A yellow aqueous oral suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and sheep. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _Triazole _is a combination product for the treatment of the common nematode parasites (including lung worm - _Dictyocaulus _spp.) and liver fluke (_Fasciola hepatica) _of cattle and sheep. Triazole is active against: _Fasciola hepatica _(mature and immature over 8 weeks of age) _Nematodirus _spp. _Dictyocaulus _spp. _Ostertagia _spp. (except inhibited ostertagia larvae) 4.3 CONTRAINDICATIONS Do not use in concurrent treatment with organophosphates and / or diethylcarbamazine. Do not use in animals with known hypersensitivity to the active ingredients. Each ml contains: ACTIVE SUBSTANCES Levamisole Hydrochloride 15 mg Rafoxanide 22.5 mg EXCIPIENTS Sodium Metabisulphite (E223) 0.5 mg Propyl Parahydroxybenzoate(E216) 0.1 mg Methyl Parahydroxybenzoate(E218) 1.0 mg Quinoline Yellow (E104) 0.09 mg IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 31/05/2013_ _CRN 7014678_ _page number: 1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: - Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. - Underdosing which may be due to underestimation of bodyweight, misadministration of the product, or lack of calibration of the dosing device. Sus Lire le document complet